Synthesis 2011(24): 3965-3974  
DOI: 10.1055/s-0031-1289607
FEATUREARTICLE
© Georg Thieme Verlag Stuttgart ˙ New York

Novel σ1 Receptor Ligands by Oxa-Pictet-Spengler Reaction of Pyrazolylethanol

Torsten Schläger, Dirk Schepmann, Bernhard Wünsch*
Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Hittorfstraße 58-62, 48149 Münster, Germany
Fax: +49(251)8332144; e-Mail: wuensch@uni-muenster.de;
Further Information

Publication History

Received 30 August 2011
Publication Date:
15 November 2011 (online)

Abstract

The oxa-Pictet-Spengler reaction of 2-(1-phenylpyrazol-5-yl)ethanol required the weak acid pyridinium p-toluenesulfonate to provide pyrano[4,3-c]pyrazoles with additional functional groups in the side chain. These functional groups allow the introduction of various amino substituents into the side chain in position 4. In receptor binding studies the aminoethyl-substituted pyranopyrazoles revealed higher σ1 receptor affinities and σ12 selectivities than the shorter aminomethyl homologues. The pyranopyrazole bearing the phenylpiperidine substituent (K i = 0.99 nM) represents the most potent and that bearing the piperidine substituent the most selective (σ12 = 180) σ1 ligands of this series of compounds.

    References

  • 1 Kitaichi K. Chabot JG. Moebius FF. Flandorfer A. Glossmann H. Quirion R. J. Chem. Neuroanat.  2000,  20:  375 
  • 2 Alonso G. Phan V. Guillemain I. Saunier M. Legrand A. Anoal M. Maurice T. Neuroscience  2000,  97:  155 
  • 3 Hayashi T. Su TP. CNS Drugs  2004,  18:  269 
  • 4 Cobos EJ. Entrena JM. Nieto FR. Cendan CM. DelPezo E. Curr. Pharmacol.  2008,  6:  344 
  • 5 Maurice T. Su TP. Pharmacol. Ther.  2009,  124:  195 
  • 6 Ishikawa M. Hashimoto K. J. Receptor Ligand Channel Res.  2010,  3:  25 
  • 7 Mach RH. Wheeler KT. Cent. Nerv. Syst. Agents Med. Chem.  2009,  9:  230 
  • 8 Diaz JL. Zamanillo D. Corbera J. Baeyens JM. Maldonado R. Pericas MA. Vela JM. Torrens A. Cent. Nerv. Syst. Agents Med. Chem.  2009,  9:  172 
  • 9 Corbera AJ. Vaño D. Martínez D. Vela JM. Zamanillo D. Dordal A. Andreu F. Hernandez E. Perez R. Escriche M. Salgado L. Yeste S. Serafini MT. Pascual R. Alegre J. Calvet MC. Cano N. Carro M. Buschmann H. Holenz J. ChemMedChem  2006,  1:  140 
  • 10 Entrena JM. Cobos EJ. Nieto FR. Cendan CM. Gris G. Del Pozo E. Zampanillo D. Baeyens JM. Pain  2009,  143:  252 
  • 11 Corbera AJ, Cuberes-Altisent MR, Holenz J, Martinez-Olmo D, and Vano-Domenech D. inventors; WO  2006,021,463. 
  • 12 Schläger T. Schepmann D. Lehmkuhl K. Holenz J. Vela JM. Buschmann H. Wünsch B. J. Med. Chem.  2011,  54:  6704 
  • 13 Wünsch B. Zott M. Liebigs Ann. Chem.  1992,  39 
  • 14 Larghi EL. Kaufman TS. Synthesis  2006,  187 
  • 15 Larghi EL. Kaufman TS. Eur. J. Org. Chem.  2011,  5195 
  • 16 Bouguerne B. Lherbet C. Baltas M. Lett. Org. Chem.  2010,  7:  420 
  • 17 Bouguerne B. Hoffmann P. Lherbet C. Synth. Commun.  2010,  40:  915 
  • 18 Schläger T. Oberdorf C. Tewes B. Wünsch B. Synthesis  2008,  1793 
  • 19 Schomaker JM. Pulgam VR. Borhan B. J. Am. Chem. Soc.  2004,  126:  13600 
  • 20 Dess DB. Martin JC. J. Org. Chem.  1983,  48:  4155 
  • 21 Abdel-Magid AF. Mehrmann SJ. Org. Process Res. Dev.  2006,  10:  971 
  • 22 Maier CA. Wünsch B. J. Med. Chem.  2002,  45:  438 
  • 23 Große Maestrup E. Wiese C. Schepmann D. Hiller A. Fischer S. Scheunemann M. Brust P. Wünsch B. Bioorg. Med. Chem.  2009,  17:  3630 
  • 24 Holl R. Schepmann D. Fröhlich R. Grünert R. Bednarski PJ. Wünsch B. J. Med. Chem.  2009,  52:  2126